{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:09:57Z","timestamp":1791216597669,"version":"4.1.0"},"reference-count":36,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.3892\/mmr.2013.1320","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T08:08:09Z","timestamp":1360829289000},"page":"1081-1085","source":"Crossref","is-referenced-by-count":26,"title":["Low-grade inflammation in the rectum of patients with sporadic irritable bowel syndrome"],"prefix":"10.3892","volume":"7","author":[{"given":"MAGDY","family":"EL-SALHY","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DORIS","family":"GUNDERSEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JAN GUNNAR","family":"HATLEBAKK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TRYGVE","family":"HAUSKEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"key20180108011539_b1-mmr-07-04-1081","volume-title":"Irritable Bowel Syndrome","author":"El-Salhy","year":"2012"},{"key":"key20180108011539_b2-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/0016-5085(95)90373-9","article-title":"Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time","volume":"109","author":"Agr\u00e9us","year":"1995","journal-title":"Gastroenterology"},{"key":"key20180108011539_b3-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0016-5085(80)90142-0","article-title":"Functional bowel disorders in apparently healthy people","volume":"79","author":"Thompson","year":"1980","journal-title":"Gastorenterology"},{"key":"key20180108011539_b4-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gut.43.6.770","article-title":"Irritable bowel syndrome, gastro-oesophageal reflux, and bronchial hyper-responsiveness in the general population","volume":"43","author":"Kennedy","year":"1998","journal-title":"Gut"},{"key":"key20180108011539_b5-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/BF01303162","article-title":"U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact","volume":"38","author":"Drossman","year":"1993","journal-title":"Dig Dis Sci"},{"key":"key20180108011539_b6-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/0016-5085(95)90738-6","article-title":"Medical costs in community subjects with irritable bowel syndrome","volume":"109","author":"Talley","year":"1995","journal-title":"Gastroenterology"},{"key":"key20180108011539_b7-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1046\/j.1365-2036.2003.01456.x","article-title":"The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40,000 subjects","volume":"17","author":"Hungin","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108011539_b8-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/bmj.304.6819.87","article-title":"Irritable bowel syndrome in the general population","volume":"304","author":"Jones","year":"1992","journal-title":"BMJ"},{"key":"key20180108011539_b9-mmr-07-04-1081","first-page":"451","article-title":"Functional disorders of the colon","volume":"58","author":"Bordie","year":"1972","journal-title":"J Indian Med Assoc"},{"key":"key20180108011539_b10-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"M184","DOI":"10.1093\/gerona\/50A.4.M184","article-title":"Bowel disorders impair functional status and quality of life in the elderly: a population-based study","volume":"50","author":"O\u2019Keefe","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"key20180108011539_b11-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/0016-5085(91)90275-P","article-title":"Irritable bowel syndrome in office-based practice in the United States","volume":"100","author":"Everhart","year":"1991","journal-title":"Gastroenterology"},{"key":"key20180108011539_b12-mmr-07-04-1081","first-page":"495","article-title":"Prevalence of irritable bowel syndrome: a community survey","volume":"54","author":"Wilson","year":"2004","journal-title":"Br J Gen Pract"},{"key":"key20180108011539_b13-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0140-6736(83)91802-0","article-title":"Organic and functional disorders in 2000 gastroenterology outpatients","volume":"1","author":"Harvey","year":"1983","journal-title":"Lancet"},{"key":"key20180108011539_b14-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s11894-009-0039-x","article-title":"The burden of IBS: looking at metrics","volume":"11","author":"Spiegel","year":"2009","journal-title":"Curr Gastroenterol Rep"},{"key":"key20180108011539_b15-mmr-07-04-1081","first-page":"17","article-title":"A world view of IBS","volume-title":"Irritable Bowel Syndrome: Diagnosis and Treatment","author":"Thompson","year":"2002"},{"key":"key20180108011539_b16-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1365-2036.2006.02989.x","article-title":"Prevalence and management of abdominal cramping and pain: a multinational survey","volume":"24","author":"Quigley","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108011539_b17-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00004836-200408000-00004","article-title":"Gender and irritable bowel syndrome: the male connection","volume":"38","author":"Miller","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"key20180108011539_b18-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1007\/BF02071408","article-title":"Impact of irritable bowel syndrome on quality of life","volume":"41","author":"Whitehead","year":"1996","journal-title":"Dig Dis Sci"},{"key":"key20180108011539_b19-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1053\/gast.2000.16484","article-title":"The impact of irritable bowel syndrome on health related quality of life","volume":"119","author":"Gralnek","year":"2000","journal-title":"Gastroenterology"},{"issue":"Suppl 2","key":"key20180108011539_b20-mmr-07-04-1081","first-page":"145","article-title":"Diferencias en la calidad de vida (CV) entre pacientes con sindrome de Intestino irritable (SII) y la poblacon mexicana evaluadas mediante el SF-36","volume":"66","author":"Huerta","year":"2001","journal-title":"Rev Mex Gastroenterol"},{"issue":"Suppl-Resumenes","key":"key20180108011539_b21-mmr-07-04-1081","first-page":"50","article-title":"Los pacientes con trastornos funcionales digestivos (TFD) tienen major compromiso de la calidad de vida (CV) evaluadas por el SF-36 comparados con pacientes con hepatitis C y pancreatitis cronica","volume":"65","author":"Schmulson","year":"2000","journal-title":"Rev Mex Gastroenterol"},{"key":"key20180108011539_b22-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1007\/BF01303164","article-title":"Terminal ileal mucosal mast cells in irritable bowel syndrome","volume":"38","author":"Weston","year":"1993","journal-title":"Dig Dis Sci"},{"key":"key20180108011539_b23-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2982.2000.00221.x","article-title":"Increased mast cells in the irritable bowel syndrome","volume":"12","author":"O\u2019Sullivan","year":"2000","journal-title":"Neurogastroenterol Motil"},{"key":"key20180108011539_b24-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1053\/j.gastro.2003.09.028","article-title":"Relative importance of enterochromaffin cell hyperplasia, anxiety and depression in post-infectious IBS","volume":"125","author":"Dunlop","year":"2003","journal-title":"Gastroenterology"},{"key":"key20180108011539_b25-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1053\/j.gastro.2003.11.055","article-title":"Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome","volume":"126","author":"Barbara","year":"2004","journal-title":"Gastroenterology"},{"key":"key20180108011539_b26-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1136\/gut.47.6.804","article-title":"Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome","volume":"47","author":"Spiller","year":"2000","journal-title":"Gut"},{"key":"key20180108011539_b27-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/ajg.2008.94","article-title":"Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms","volume":"104","author":"Cremon","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"key20180108011539_b28-mmr-07-04-1081","article-title":"Duodenal mucosal lymphocytes in Giardia-induced functional gastrointestinal disorder","author":"Dizdar","year":"2011"},{"key":"key20180108011539_b29-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","journal-title":"Gastroenterology"},{"key":"key20180108011539_b30-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1440-1746.2009.06133.x","article-title":"Bugs and irritable bowel syndrome: The good, the bad and the ugly","volume":"25","author":"Ghoshal","year":"2010","journal-title":"J Gastroenterol Hepatol"},{"key":"key20180108011539_b31-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/j.1365-2982.2006.00821.x","article-title":"Postinfectious irritable bowel syndrome may occur after non-gastrointestinal and intestinal infection","volume":"18","author":"Mckeown","year":"2006","journal-title":"Neurogastroenterol Motil"},{"key":"key20180108011539_b32-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1046\/j.1365-2036.2001.01010.x","article-title":"Characteristics of patients with irritable bowel syndrome recruited from three sources: implications for clinical trials","volume":"15","author":"Longstreth","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"key20180108011539_b33-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.dld.2009.07.007","article-title":"Infection, inflammation and the irritable bowel syndrome","volume":"41","author":"Spiller","year":"2009","journal-title":"Dig Liver Dis"},{"key":"key20180108011539_b34-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2982.2005.00719.x","article-title":"Enterochromaffin cell hyperplasia and decreased serotonin transporter in a mouse model of postinfectious bowel dysfunction","volume":"17","author":"Wheatcroft","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"key20180108011539_b35-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/gut.2003.021154","article-title":"Bacillary dysentery as a causative factor for irritable bowel syndrome and its pathogenesis","volume":"53","author":"Wang","year":"2004","journal-title":"Gut"},{"key":"key20180108011539_b36-mmr-07-04-1081","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1440-1746.2008.05574.x","article-title":"The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors","volume":"23","author":"Lee","year":"2008","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Molecular Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/mmr.2013.1320\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T14:57:18Z","timestamp":1562684238000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/mmr.2013.1320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,2,14]]},"published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.3892\/mmr.2013.1320"],"URL":"https:\/\/doi.org\/10.3892\/mmr.2013.1320","relation":{},"ISSN":["1791-2997","1791-3004"],"issn-type":[{"value":"1791-2997","type":"print"},{"value":"1791-3004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}